To develop and evaluate the long-term prophylactic treatment for chronic diseases such as osteoporosis requires a clear view of mechanism at the molecular and systems level. While molecular signaling pathway studies for osteoporosis are extensive, a unifying mechanism is missing. In this work, we provide experimental and systems-biology evidences that a tightly connected top-level regulatory network may exist, which governs the normal and osteoporotic phenotypes of osteoblast. Specifically, we constructed a hub-like interaction network from well-documented cross-talks among estrogens, glucocorticoids, retinoic acids, peroxisome proliferator-activated receptor, vitamin D receptor and calcium-signaling pathways. The network was verified with transmission electron microscopy and gene expression profiling for bone tissues of ovariectomized (OVX) rats before and after strontium gluconate (GluSr) treatment. Based on both the network structure and the experimental data, the dynamical modeling predicts calcium and glucocorticoids signaling pathways as targets for GluSr treatment. Modeling results further reveal that in the context of missing estrogen signaling, the GluSr treated state may be an outcome that is closest to the healthy state.
Core level regulatory network of osteoblast as molecular mechanism for osteoporosis and treatment
R. Yuan,Shengfei Ma,Xiaomei Zhu,Jun Li,Yuhong Liang,Tao Liu,Yanxia Zhu,Bingbing Zhang,Shuang Tan,Huajie Guo,S. Guan,P. Ao,Guangqian Zhou
Published 2016 in OncoTarget
ABSTRACT
PUBLICATION RECORD
- Publication year
2016
- Venue
OncoTarget
- Publication date
2016-01-15
- Fields of study
Biology, Medicine
- Identifiers
- External record
- Source metadata
Semantic Scholar, PubMed
CITATION MAP
EXTRACTION MAP
CLAIMS
- No claims are published for this paper.
CONCEPTS
- No concepts are published for this paper.
REFERENCES
Showing 1-58 of 58 references · Page 1 of 1
CITED BY
Showing 1-18 of 18 citing papers · Page 1 of 1